Takanobu Masuda
Overview
Explore the profile of Takanobu Masuda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tokunaga E, Masuda T, Ijichi H, Tajiri W, Koga C, Koi Y, et al.
Breast Cancer
. 2021 Sep;
29(1):156-163.
PMID: 34487328
Background: Several studies have recently reported that the relationships between serum vitamin D and the prognosis or the pathological response to neoadjuvant chemotherapy (NAC) in breast cancer. However, there are...
2.
Jahan M, Ito T, Ichihashi S, Masuda T, Bhuiyan M, Takahashi I, et al.
IBRO Rep
. 2020 Nov;
9:276-289.
PMID: 33163687
PlexinA1 (PlxnA1) is a transmembrane receptor for semaphorins, a large family of proteins that act as axonal guidance cues during nervous system development. However, there are limited studies on PlxnA1...
3.
Tajiri W, Ijichi H, Takizawa K, Koi Y, Masuda T, Ueo H, et al.
Breast Cancer
. 2020 Jul;
28(1):67-74.
PMID: 32601800
Background: Clinical Treatment Score post-5 years (CTS5) is a promising prognostic tool to evaluate late distant recurrence (DR) risk for breast cancer after 5-year adjuvant endocrine therapy. Patients And Methods:...
4.
Okamoto M, Tajiri W, Ueo H, Masuda T, Ijichi H, Koga C, et al.
Anticancer Res
. 2020 Jun;
40(6):3315-3323.
PMID: 32487627
Background/aim: To evaluate the improvement in the prognosis by adjuvant trastuzumab in clinical practice and the risk factors for distant recurrence, we retrospectively investigated the prognosis of HER2-positive early breast...
5.
Tokunaga E, Ijichi H, Tajiri W, Masuda T, Takizawa K, Ueo H, et al.
Breast Cancer
. 2020 May;
27(6):1137-1146.
PMID: 32472474
Background: The TNM system, which reflects the anatomical extent of disease, was used for stage definition. In the recently published AJCC 8th edition, the new staging system of the clinical...
6.
Tokunaga E, Fujita A, Takizawa K, Baba K, Akiyoshi S, Nakamura Y, et al.
Breast Cancer
. 2018 Jul;
26(1):47-57.
PMID: 29971631
Background: Neoadjuvant chemotherapy (NAC) is the standard therapeutic strategy for triple-negative breast cancer (TNBC). TNBC patients with residual disease after NAC have a significantly worse survival than those with pathological...
7.
Koi Y, Koga C, Akiyoshi S, Masuda T, Ijichi H, Nakamura Y, et al.
Anticancer Res
. 2018 Mar;
38(3):1579-1584.
PMID: 29491088
Background: Previous studies have suggested that the presence of visceral metastasis is a parameter useful in predicting the treatment efficacy of fulvestrant in patients with advanced breast cancer. Patients And...
8.
Kayashima H, Maeda T, Harada N, Masuda T, Ohmine T, Yamaguchi S, et al.
Surg Case Rep
. 2016 Mar;
2(1):24.
PMID: 26976614
Background: Pancreatoduodenectomy (PD) is an extensive surgery, and its complications are grave. Acute ischemia of the jejunal loop due to thrombosis of the superior mesenteric vein (SMV) and its branches...
9.
Kayashima H, Maeda T, Harada N, Masuda T, Guntani A, Ito S, et al.
Surgery
. 2015 Jun;
158(6):1669-75.
PMID: 26116049
Background: The risk factors for incisional hernia (IH) and the association between liver fibrosis and IH after hepatic resection in patients with hepatocellular carcinoma (HCC) with liver cirrhosis (LC) are...
10.
Masuda T, Nakashima Y, Ando K, Yoshinaga K, Saeki H, Oki E, et al.
Anticancer Res
. 2014 Nov;
34(11):6397-403.
PMID: 25368239
Background: The CXCL12/CXCR4 axis plays a pivotal role in cancer progression and metastases in various epithelial cancer cells. The aim of the present study was to evaluate the localization and...